MEDICAL GRADE HYDROXYPROPYL CELLULOSE MARKET REPORT OVERVIEW
-
Request a Free Sample to learn more about this report
The global medical grade hydroxypropyl cellulose market size was USD 45 million in 2020 and will touch USD 65 million by 2026, exhibiting a CAGR of 6.2% during the forecast period.
Medical-grade hydroxypropyl cellulose (HPC) is a versatile polymer that finds extensive use in the pharmaceutical and medical industries. As a derivative of cellulose, HPC is modified to exhibit specific properties that make it suitable for various applications in drug formulations and medical devices. One of its primary functions is as a pharmaceutical excipient, serving as a binder, disintegrant, and film-former in the production of tablets and capsules. Its ability to dissolve in water and form clear, viscous solutions makes it an ideal ingredient for oral solid dosage forms, enabling controlled drug release and enhancing bioavailability.
Moreover, medical-grade hydroxypropyl cellulose is recognized for its biocompatibility and safety, making it suitable for use in medical devices and ophthalmic formulations. In ophthalmology, HPC is often employed in the production of artificial tears and eye drops, contributing to the lubrication and protection of the ocular surface. Its non-irritating nature and ability to form a clear and stable solution make it well-suited for formulations designed to alleviate dry eye symptoms. As a medical-grade material, HPC undergoes rigorous quality control measures to ensure compliance with pharmaceutical standards, making it a reliable and trusted component in various healthcare applications.
COVID-19 Impact: Market Growth Boosted by Pandemic due to Increased Demand for Pharmaceuticals
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The pandemic led to disruptions in global supply chains due to lockdowns, restrictions on movement, and changes in consumer behavior. These disruptions could have affected the sourcing and transportation of raw materials needed for the production of medical-grade HPC. Regulatory processes in the pharmaceutical industry faced challenges as regulatory agencies adapted to the unprecedented circumstances. This could have affected the approval processes for new products or the introduction of changes to existing ones, including those involving medical-grade HPC.
The pharmaceutical industry experienced increased demand for certain products, particularly those related to COVID-19 treatment and prevention. This surge in demand for pharmaceuticals may have influenced the production priorities and capacities of companies involved in manufacturing pharmaceutical excipients, including medical-grade HPC. The pandemic prompted an intensified focus on drug development and the production of essential medical supplies. Companies may have shifted resources toward developing and manufacturing treatments and vaccines, potentially impacting the production of non-essential pharmaceutical components. The global medical grade hydroxypropyl cellulose market growth is anticipated to boost following the pandemic.
LATEST TRENDS
"Growing Demand for Pharmaceutical Excipients to Drive Market Growth"
The pharmaceutical industry is experiencing increased demand for excipients as essential components in drug formulations. Medical-grade HPC, known for its versatility and compatibility with various drugs, is likely to see continued demand as drug developers seek effective excipients for oral solid dosage forms.
There is a continued emphasis on developing patient-friendly dosage forms, such as orally disintegrating tablets and quick-dissolve formulations. Medical-grade HPC's ability to act as a disintegrant and binder in such formulations positions it favorably in the trend toward enhancing patient compliance and ease of administration.
Pharmaceutical research is increasingly focusing on controlled drug release formulations to optimize therapeutic outcomes. Medical-grade HPC, with its film-forming properties and ability to contribute to sustained drug release, may play a role in these advancements. Beyond pharmaceutical formulations, the use of biocompatible materials in medical devices is a growing trend. Medical-grade HPC's biocompatibility and safety profile make it suitable for applications in ophthalmic devices and drug-eluting coatings on medical implants.
MEDICAL GRADE HYDROXYPROPYL CELLULOSE MARKET SEGMENTATION
-
Request a Free Sample to learn more about this report
- By Type
Based on type the global market can be categorized into L-HPC and H-HPC.
L-HPC: L-HPC is a type of hydroxypropyl cellulose, which is a cellulose derivative. It is characterized by a low degree of substitution, meaning that a relatively small number of hydroxypropyl groups are attached to the cellulose backbone. L-HPC is often used as a pharmaceutical excipient in the formulation of various drug dosage forms. Its unique properties make it suitable for applications such as tablet binder, disintegrant, and film-former. L-HPC is known for its good solubility in both water and organic solvents, making it versatile for use in different drug delivery systems. It contributes to the stability and bioavailability of drugs and is widely employed in the pharmaceutical industry for its compatibility with a range of active pharmaceutical ingredients.
H-HPC: H-HPC, on the other hand, refers to High-Substituted Hydroxypropyl Cellulose. Unlike L-HPC, H-HPC has a higher degree of substitution, indicating a greater number of hydroxypropyl groups attached to the cellulose backbone. The higher substitution imparts different properties to H-HPC compared to its low-substituted counterpart. H-HPC is also utilized in pharmaceutical formulations, and its characteristics may include enhanced viscosity, gel-forming abilities, and film-forming properties. It may be employed in drug delivery systems where its specific features are advantageous, such as in the preparation of controlled-release dosage forms.
- By Application
Based on application the global market can be categorized into Disintegrator and Film Former.
Disintegrator: In pharmaceutical formulations, a disintegrator is an excipient that facilitates the breakdown or disintegration of a solid dosage form, such as tablets, into smaller particles upon exposure to moisture or upon contact with fluids in the gastrointestinal tract. The primary goal of a disintegrator is to promote the rapid release of the active pharmaceutical ingredient (API) for absorption. Common disintegrants include substances like croscarmellose sodium, crospovidone, sodium starch glycolate, and low-substituted hydroxypropyl cellulose (L-HPC).
Film Former: A film former in pharmaceuticals refers to an excipient that is used to create a thin, uniform film coating on the surface of tablets or capsules. This coating serves various purposes, such as improving the appearance, taste masking, protecting the drug from environmental factors, and facilitating ease of swallowing. Film formers contribute to the overall stability and performance of the dosage form. Common film-forming agents include hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC), ethyl cellulose, and polyvinyl alcohol.
DRIVING FACTORS
"Pharmaceutical Formulations to Boost the Market"
Medical-grade HPC serves as a critical excipient in pharmaceutical formulations. It is utilized as a binder, disintegrant, film-former, and viscosity modifier in the production of tablets, capsules, and other oral solid dosage forms. The growing pharmaceutical industry, driven by increasing healthcare needs globally, contributes to the demand for high-quality excipients like medical-grade HPC. Medical-grade HPC is known for its biocompatibility and safety. It is widely used in medical and pharmaceutical applications where direct contact with the human body is involved, such as in ophthalmic formulations, artificial tears, and other medical devices. The material's non-toxic and non-irritating properties make it suitable for various healthcare products.
"Ophthalmic Formulations to Expand the Market"
The ophthalmic industry utilizes medical-grade HPC in the formulation of eye drops, artificial tears, and other ophthalmic solutions. Its ability to form clear and stable solutions, as well as its biocompatibility, makes it a preferred choice for maintaining ocular health and addressing conditions like dry eyes. The rising prevalence of eye-related issues contributes to the demand for advanced ophthalmic formulations. Ongoing research in pharmaceuticals emphasizes controlled drug release for optimized therapeutic outcomes. Medical-grade HPC's film-forming properties and its ability to contribute to sustained drug release make it valuable in formulations designed for controlled release of active pharmaceutical ingredients.
RESTRAINING FACTOR
"Competition from Alternative Excipients to Potentially Impede Market Growth"
The pharmaceutical and medical industries have a range of excipients available for various purposes. Depending on specific formulation requirements, manufacturers may opt for alternative excipients that offer similar functionalities at a lower cost or with different properties. Competition from such alternatives can impact the market share of medical-grade HPC. While medical-grade HPC has diverse applications, its use may be specific to certain formulations or medical devices. If the excipient is not suitable for a particular application or if alternative excipients better meet specific requirements, it may face limitations in broader market adoption.
MEDICAL GRADE HYDROXYPROPYL CELLULOSE MARKET REGIONAL INSIGHTS
-
Request a Free Sample to learn more about this report
"North America to Dominate the Market due to Technological Innovations "
The market is primarily segmented into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
North America has emerged as the most dominant region in the global medical grade hydroxypropyl cellulose market share due to several factors. The region is home to a robust and influential pharmaceutical industry. The region is a hub for pharmaceutical research, development, and manufacturing. The demand for high-quality excipients like medical-grade HPC is driven by the extensive production of pharmaceuticals in North America.
KEY INDUSTRY PLAYERS
"Key Industry Players Shaping the Market through Innovation and Market Expansion"
The medical grade hydroxypropyl cellulose market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of wardrobe options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development, introducing innovative designs, materials, and smart features in cloth wardrobes, catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.
List of Market Players Profiled
- Shin-Etsu Chemical Co., Ltd. [Japan]
- Lotte Fine Chemicals [South Korea]
- Shandong Everbright [China]
- Shandong Heda [China]
- Shandong Yiteng [China]
INDUSTRIAL DEVELOPMENT
October 2023: Ashland Global Specialty Chemicals took significant strives ahead in the medical grade hydroxypropyl cellulose market. It recently developed KLUCEL™ EXF (Medical Grade Hydroxypropyl Cellulose). KLUCEL™ EXF is a type of medical-grade hydroxypropyl cellulose offered by Ashland. It is commonly used in pharmaceutical formulations and medical applications, serving various purposes such as a binder, film-former, and viscosity modifier. This product is known for its high purity and biocompatibility, making it suitable for use in oral solid dosage forms, ophthalmic formulations, and other medical and pharmaceutical applications.
REPORT COVERAGE
The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 45 Million in 2020 |
Market Size Value By |
US$ 65 Million by 2026 |
Growth Rate |
CAGR of 6.2% from 2020 to 2026 |
Forecast Period |
2022-2026 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is the medical grade hydroxypropyl cellulose market expected to touch by 2026?
The global medical grade hydroxypropyl cellulose market is expected to reach USD 65 million by 2026.
-
What CAGR is the medical grade hydroxypropyl cellulose market expected to exhibit by 2026?
The medical grade hydroxypropyl cellulose market is expected to exhibit a CAGR of 6.2% by 2026.
-
Which are the driving factors of the medical grade hydroxypropyl cellulose market?
Pharmaceutical Formulations and Ophthalmic Formulations are some of the driving factors of the medical grade hydroxypropyl cellulose market.
-
What are the medical grade hydroxypropyl cellulose market segments?
The medical grade hydroxypropyl cellulose market segmentation that you should be aware of, which include, based on type the medical grade hydroxypropyl cellulose market is classified as L-HPC and H-HPC. Based on application the medical grade hydroxypropyl cellulose market is classified as Disintegrator and Film Former.